Becton, Dickinson and Co. | BDX - Current Liabilities

Stock Price
185.39
Daily Change
2.92 1.60%
Monthly
-10.08%
Yearly
-18.48%
Q1 Forecast
179.64

Becton, Dickinson and Co. reported $8.76B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Agilent USD 2.35B 455M Sep/2025
Align Technology USD 1.92B 46.45M Dec/2025
AngioDynamics USD 77.97M 10.62M Feb/2025
Avanos Medical USD 147.9M 13.3M Sep/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Danaher USD 6.81B 483M Dec/2025
Dentsply International USD 1.4B 239M Sep/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Exact Sciences USD 641.15M 56.89M Dec/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 9.94B 1.6B Sep/2025
Solventum Corp USD 2.94B 318M Sep/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Terumo JPY 539.7B 243.4B Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025